<DOC>
	<DOCNO>NCT02620631</DOCNO>
	<brief_summary>This prospective , randomize , double-blinded , placebo-controlled study design examine pain relief follow intrathecal morphine sulfate ( 0.2mg ) patient undergo total knee arthroplasty ( TKA ) spinal anesthesia addition femoral nerve catheter . The protocol consist two part : ( 1 ) prospective patient recruitment study ( 2 ) retrospective assay endocannabinoids previously collect specimen .</brief_summary>
	<brief_title>Study Examine Pain Relief With Supplemental Intrathecal Morphine TKA Patients</brief_title>
	<detailed_description>This prospective , case-controlled randomize , double-blinded , placebo-controlled study expect enroll 100 patient schedule undergo unilateral total knee arthroplasty ( TKA ) regional anesthesia ( defined intrathecal spinal + femoral nerve blockade + femoral nerve catheter post-operative analgesia ) Stony Brook Hospital . The patient randomize receive either IT morphine 0.2 mg ( Group 1 ) placebo ( Group 2 ) combination standard-of-care spinal anesthesia . Post-operatively , patient give intravenous patient-controlled analgesic opioid breakthrough pain . Only pharmacist prepare drug/placebo knowledge subject randomize . Study staff complete multiple questionnaire regard subject ' pain score patient disability pain assess change different study period ( ie . pre-operative , post-operative follow ) . Biological sample also take subject measure analyze difference change endocannabinoid level .</detailed_description>
	<mesh_term>Acute Pain</mesh_term>
	<mesh_term>Morphine</mesh_term>
	<criteria>Scheduled unilateral TKA regional anesthesia ASA Class 1 , 2 3 Able give inform consent Able understand English Medical condition ( ) prevent use regional anesthesia ( e.g . infection site injection , coagulopathy , severe hypovolemia , severe aortic mitral stenosis , increase intracranial pressure , severe spinal deformity , spinal cord hardware stimulator implant ) Allergy morphine Morbid obesity ( BMI &gt; 45 ) Respiratory compromise ( difficult airway , severe emphysema COPD ) Obstructive sleep apnea ( diagnosed sleep disorder clinic CPAP prescribed ) Chronic pain opioid usage 100 mg morphineequivalents po/day History abuse opioids drug abuse Scheduled bilateral TKA Revision knee arthroplasty Any medical condition would affect patient 's ability metabolize excrete study drug ( e.g . chronic kidney failure patient dialysis ) medical condition investigator 's opinion would render patient unsuitable research study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Morphine</keyword>
	<keyword>TKA</keyword>
	<keyword>Pain</keyword>
	<keyword>TKR</keyword>
	<keyword>Arthroplasty</keyword>
</DOC>